Probiotic-enhanced chemotherapy: Lactobacillus fermentum synergizes with vincristine to induce apoptosis via dual pathway activation in human cancer cells
摘要
Probiotics, particularly Lactobacillus species, show promise as adjuvants in cancer therapy due to their pro-apoptotic effects. This study investigated the synergistic impact of Lactobacillus fermentum (Ab.RS23) and vincristine sulfate on colorectal (HT-29) and breast (MCF-7) cancer cells.
MethodsCells were treated with vincristine, L. fermentum, or both. Cell viability was measured by MTT assay. Apoptosis was analyzed via Annexin V-FITC/PI flow cytometry. Gene expression changes were evaluated by RT-qPCR.
ResultsCo-treatment reduced the IC₅₀ of vincristine by 8-fold in HT-29 and 13-fold in MCF-7 cells. Apoptotic signaling was enhanced, with pro-apoptotic pathways upregulated and survival pathways downregulated.
ConclusionL. fermentum enhanced vincristine-induced apoptosis and reduced the required drug dose, which may contribute to lowering vincristine-associated toxicity. These findings require confirmation through in vivo studies.